tradingkey.logo
tradingkey.logo
Search

Sana Biotechnology Inc

SANA
Add to Watchlist
3.130USD
-0.120-3.69%
Close 07-31 16:00ETQuotes delayed by 15 min
871.05MMarket Cap
LossP/E TTM

SANA Financials

See Sana Biotechnology Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Sana Biotechnology Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.17/-0.17
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.96
16.55%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
17.98%-0.17
-2.58%-0.21
36.43%-0.16
-83.40%-0.39
57.97%-0.21
53.50%-0.21
-5191.00%-0.25
63.77%-0.21
-15.18%-0.49
-5.71%-0.45
--0.01
---0.59
---0.43
---0.42
---1.01
----
----
----
----
----
Net Profit
4.41%-47.21M
-19.88%-58.83M
29.66%-42.15M
-86.51%-93.80M
54.05%-49.39M
44.31%-49.07M
-6189.84%-59.92M
55.88%-50.29M
-30.87%-107.47M
-9.54%-88.12M
101.16%984.00K
-57.32%-114.00M
-161.14%-82.12M
27.35%-80.44M
-2.23%-85.12M
-504.06%-72.47M
82.59%-31.45M
2.16%-110.73M
---83.26M
120.42%17.93M
Debt to assets ratio
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Operating profit
17.45%-40.18M
26.75%-47.11M
39.95%-40.39M
48.13%-40.10M
33.07%-48.67M
23.24%-64.31M
20.68%-67.26M
13.72%-77.32M
13.36%-72.72M
3.96%-83.78M
8.08%-84.80M
1.35%-89.61M
3.66%-83.93M
28.01%-87.24M
-38.35%-92.25M
-58.04%-90.83M
51.80%-87.12M
-6.94%-121.18M
---66.68M
-59.65%-57.47M
Net Profit
4.41%-47.21M
-19.88%-58.83M
29.66%-42.15M
-86.51%-93.80M
54.05%-49.39M
44.31%-49.07M
-6189.84%-59.92M
55.88%-50.29M
-30.87%-107.47M
-9.54%-88.12M
101.16%984.00K
-57.32%-114.00M
-161.14%-82.12M
27.35%-80.44M
-2.23%-85.12M
-504.06%-72.47M
82.59%-31.45M
2.16%-110.73M
---83.26M
120.42%17.93M
Current assets
-0.92%111.69M
-7.54%148.68M
-23.03%161.76M
-68.68%82.50M
-64.91%112.73M
-24.69%160.81M
-24.82%210.15M
-22.20%263.45M
-13.15%321.26M
-51.96%213.51M
-44.12%279.52M
-31.51%338.62M
-29.30%369.91M
-20.37%444.44M
-18.37%500.25M
-42.53%494.41M
-45.92%523.22M
45.16%558.10M
34.52%612.85M
--860.34M
Total current liabilities
160.18%86.27M
73.28%78.73M
-24.45%35.51M
-34.02%33.44M
-37.32%33.16M
-29.55%45.43M
-29.47%47.00M
-54.78%50.69M
-48.53%52.90M
-42.17%64.49M
-41.95%66.64M
15.44%112.11M
9.91%102.78M
12.36%111.50M
24.78%114.81M
126.72%97.11M
166.03%93.51M
215.52%99.23M
246.72%92.01M
--42.83M
Total assets
-16.14%373.59M
-16.79%416.89M
-22.16%435.43M
-41.54%361.64M
-34.62%445.47M
-11.37%501.02M
-11.41%559.39M
-12.51%618.67M
-8.78%681.38M
-31.29%565.30M
-29.69%631.44M
-27.18%707.15M
-28.70%746.93M
-27.15%822.72M
-27.15%898.10M
-22.92%971.09M
-19.69%1.05B
54.65%1.13B
60.57%1.23B
--1.26B
Total liabilities
7.60%254.35M
2.19%256.01M
-10.04%240.12M
-14.31%239.09M
-22.81%236.39M
-9.82%250.52M
0.50%266.91M
-20.76%279.02M
-3.90%306.24M
-14.10%277.79M
-20.02%265.59M
6.19%352.12M
-7.89%318.67M
-19.33%323.40M
-17.53%332.08M
-6.32%331.58M
-18.11%345.96M
34.27%400.90M
78.18%402.67M
--353.94M
Total equity
-42.97%119.24M
-35.78%160.88M
-33.22%195.31M
-63.92%122.56M
-44.27%209.08M
-12.87%250.50M
-20.06%292.48M
-4.33%339.65M
-12.40%375.14M
-42.42%287.51M
-35.36%365.85M
-44.48%355.03M
-38.96%428.26M
-31.46%499.31M
-31.81%566.02M
-29.41%639.50M
-20.45%701.65M
68.75%728.50M
53.23%830.09M
--905.90M
Net operating income
23.18%-37.38M
30.79%-32.64M
43.21%-29.43M
43.46%-33.10M
25.86%-48.66M
9.23%-47.16M
18.46%-51.82M
0.44%-58.54M
17.21%-65.63M
31.69%-51.96M
1.92%-63.55M
17.74%-58.80M
-2.01%-79.27M
30.91%-76.07M
-28.34%-64.80M
-76.25%-71.48M
-55.69%-77.71M
-193.14%-110.10M
---50.49M
---40.56M
Net investment
197.76%49.44M
-135.03%-16.50M
-214.96%-48.02M
32.00%7.68M
121.50%16.60M
207.56%47.09M
-18.64%41.77M
-86.35%5.82M
-223.12%-77.23M
-82.69%15.31M
61.17%51.35M
-45.16%42.63M
400.02%62.73M
220.05%88.43M
117.14%31.86M
320.05%77.73M
-74.45%12.54M
-664.84%-73.66M
---185.90M
---35.32M
Net financing
-113.03%-128.00K
2644.95%17.65M
5161.29%109.54M
-94.72%561.00K
-99.47%982.00K
-62.57%643.00K
1013.37%2.08M
-63.98%10.63M
78881.78%186.40M
61.92%1.72M
-88.46%187.00K
1768.59%29.50M
-63.80%236.00K
-65.98%1.06M
1.57%1.62M
374.17%1.58M
-99.90%652.00K
2928.16%3.12M
--1.60M
--333.00K

FAQs

What are the current assets of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its current assets were 148.68M, with a year-on-year change of -7.54.

What are the total assets of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its total assets of Sana Biotechnology Inc were 416.89M, with a year-on-year change of -16.79.

What are the total liabilities of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its total liabilities of Sana Biotechnology Inc were 256.01M, with a year-on-year change of 2.19.

What is the total equity of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its total equity of Sana Biotechnology Inc was 160.88M, with a year-on-year change of -35.78.

What is the net operating income of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its net operating income of Sana Biotechnology Inc was -176.28M, with a year-on-year change of 37.40.

What is the net investment of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its net investment of Sana Biotechnology Inc was -40.24M, with a year-on-year change of -330.55.

What is the net financing of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its net financing of Sana Biotechnology Inc was 128.73M, with a year-on-year change of -35.55.

What is the Earnings Per Share (EPS) of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.96, with a year-on-year change of 16.55.

What is the net income of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its net income was -244.17M, with a year-on-year change of 8.47.

What is the Return on Equity (ROE) of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its Return on Equity (ROE) was -118.70, with a year-on-year change of -19.70.

What is the Return on Assets (ROA) of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its Return on Assets (ROA) was -53.20, with a year-on-year change of -6.33.

What is the operating profit of Sana Biotechnology Inc?

According to Sana Biotechnology Inc's FY2025 earnings report, its operating profit was -176.28M, with a year-on-year change of 37.40.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.